EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Distinct outcome patterns according to RAS and BRAF status in MSI-H/dMMR mCRC treated with immune checkpoint inhibitors: A systematic review and meta-analysis

Andrea Pretta, Riccardo Giampieri, Andrea Bottelli, Ada Taravella, Rossana Intini, Pina Ziranu, Carolina Liguori, Federica Manoni, Matteo Landi, Giulia Maddalena, Giorgia Locci, Clelia Donisi und 12 weitere

Cancer Treatment Reviews · 2026

DOI: 10.1016/j.ctrv.2026.103178 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Cancer Treatment Reviews, 2026. Verfasst von Andrea Pretta und 23 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Unit, University Hospital and University of Cagliari, Italy. Electronic address: an.pretta@gmail.com. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Immune Checkpoint Inhibitors, Proto-Oncogene Proteins B-raf, ras Proteins. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsImmune Checkpoint InhibitorsProto-Oncogene Proteins B-rafras ProteinsHumansMicrosatellite InstabilityMutation

Stichwörter der Autor:innen

BRAFMSI-HRAScolorectal cancerdMMRimmunotherapymeta-analysis

Substanzen

BRAF protein, humanImmune Checkpoint InhibitorsProto-Oncogene Proteins B-rafras Proteins

Autor:innen und Institutionen

  • Medical Oncology Unit, University Hospital and University of Cagliari, Italy. Electronic address: an.pretta@gmail.com.
  • Clinica Oncologica - Dipartimento Scienze Cliniche e Molecolari - Università Politecnica delle Marche, Italy; Azienda Ospedaliero Universitaria delle Marche -Ancona, Italy.
  • Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Unit of Oncology, University Hospital of Pisa, Italy; Department of Translational Research & New Technologies in Medicine & Surgery, University of Pisa, Italy.
  • Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Medical Oncology Unit, University Hospital and University of Cagliari, Italy.

Zitieren

APA

Pretta, A., Giampieri, R., Bottelli, A., Taravella, A., Intini, R., Ziranu, P., Liguori, C., Manoni, F., Landi, M., Maddalena, G., Locci, G., Donisi, C., Masiello, M., Caschili, M., Bassetti, A., Pasquinucci, V., Maccioni, A., Sperotto, S., Bergamo, F., …, & Scartozzi, M. (2026). Distinct outcome patterns according to RAS and BRAF status in MSI-H/dMMR mCRC treated with immune checkpoint inhibitors: A systematic review and meta-analysis. Cancer Treatment Reviews. https://doi.org/10.1016/j.ctrv.2026.103178

Vancouver

Pretta A, Giampieri R, Bottelli A, Taravella A, Intini R, Ziranu P, et al. Distinct outcome patterns according to RAS and BRAF status in MSI-H/dMMR mCRC treated with immune checkpoint inhibitors: A systematic review and meta-analysis. Cancer Treatment Reviews. 2026. doi:10.1016/j.ctrv.2026.103178

BibTeX
@article{Pretta2026,
  author = {Pretta, Andrea and Giampieri, Riccardo and Bottelli, Andrea and Taravella, Ada and Intini, Rossana and Ziranu, Pina and Liguori, Carolina and Manoni, Federica and Landi, Matteo and Maddalena, Giulia and Locci, Giorgia and Donisi, Clelia and Masiello, Mariapaola and Caschili, Matteo and Bassetti, Anna and Pasquinucci, Valentino and Maccioni, Antonio and Sperotto, Sara and Bergamo, Francesca and Berardi, Rossana and Pietrantonio, Filippo and Cremolini, Chiara and Lonardi, Sara and Scartozzi, Mario},
  title = {Distinct outcome patterns according to RAS and BRAF status in MSI-H/dMMR mCRC treated with immune checkpoint inhibitors: A systematic review and meta-analysis},
  journal = {Cancer Treatment Reviews},
  year = {2026},
  doi = {10.1016/j.ctrv.2026.103178}
}
Kostenlos starten →